D-0045-2027 Class II Ongoing
FDA drug recall D-0045-2027 was initiated by Ascend Laboratories, LLC on Oct 6, 2026 and is designated Class II. Reason for recall: Out of specification due to dissolution. The recall status is ongoing. Affected quantity: 11,424 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 28, 2026
- Initiation Date
- Oct 6, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,424 bottles.
Product description
Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.
Reason for recall
Out of specification due to dissolution.
Distribution pattern
Nationwide within the United States
Code information
Lot # 25120696, Exp Date: December 31, 2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0045-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026